Scott G Ginn Amedisys Inc (AMED) insider trading activity

Scott G Ginn is EVP, CFO & COO of AMEDISYS INC. Currently has a direct ownership of 80,786 shares of AMED, which is worth approximately $7.27 Million. The most recent transaction as insider was on Jun 26, 2024, when has been sold 2,391 shares (Common Stock) at a price of $92.0 per share, resulting in proceeds of $219,972. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 80.8K

0% 3M change

15.67% 12M change

Total Value Held $7.27 Million

Scott G Ginn Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 26 2024	SELL Payment of exercise price or tax liability	$219,972 $92.0 p/Share	2,391 Reduced 2.87%	80,786 Common Stock
Feb 20 2024	SELL Payment of exercise price or tax liability	$301,494 $93.69 p/Share	3,218 Reduced 3.72%	83,177 Common Stock
Feb 16 2024	BUY Grant, award, or other acquisition	-	16,553 Added 16.08%	86,395 Common Stock
Jun 26 2023	BUY Grant, award, or other acquisition	-	16,446 Added 19.06%	69,842 Common Stock
Feb 23 2023	BUY Grant, award, or other acquisition	-	4,087 Added 7.11%	53,396 Common Stock
Feb 20 2023	SELL Payment of exercise price or tax liability	$214,432 $97.16 p/Share	2,207 Reduced 4.28%	49,309 Common Stock
Nov 21 2022	BUY Grant, award, or other acquisition	-	23,109 Added 30.97%	51,516 Common Stock
Feb 20 2022	SELL Payment of exercise price or tax liability	$278,613 $141.07 p/Share	1,975 Reduced 6.5%	28,407 Common Stock
Feb 17 2022	BUY Grant, award, or other acquisition	-	2,618 Added 7.93%	30,382 Common Stock
Oct 18 2021	SELL Payment of exercise price or tax liability	$192,456 $160.38 p/Share	1,200 Reduced 4.14%	27,764 Common Stock
Jul 19 2021	SELL Payment of exercise price or tax liability	$36,971 $254.97 p/Share	145 Reduced 0.5%	28,964 Common Stock
May 28 2021	SELL Open market or private sale	$255,060 $261.6 p/Share	975 Reduced 3.24%	29,109 Common Stock
May 28 2021	BUY Exercise of conversion of derivative security	$26,666 $27.35 p/Share	975 Added 3.14%	30,084 Common Stock
Apr 30 2021	SELL Open market or private sale	$276,247 $283.33 p/Share	975 Reduced 3.24%	29,109 Common Stock
Apr 30 2021	BUY Exercise of conversion of derivative security	$26,666 $27.35 p/Share	975 Added 3.14%	30,084 Common Stock
Mar 31 2021	SELL Open market or private sale	$253,890 $260.4 p/Share	975 Reduced 3.24%	29,109 Common Stock
Mar 31 2021	BUY Exercise of conversion of derivative security	$26,666 $27.35 p/Share	975 Added 3.14%	30,084 Common Stock
Feb 26 2021	SELL Open market or private sale	$257,546 $264.15 p/Share	975 Reduced 3.24%	29,109 Common Stock
Feb 26 2021	BUY Exercise of conversion of derivative security	$26,666 $27.35 p/Share	975 Added 3.14%	30,084 Common Stock
Feb 20 2021	SELL Payment of exercise price or tax liability	$365,600 $292.48 p/Share	1,250 Reduced 4.12%	29,109 Common Stock
Feb 17 2021	SELL Payment of exercise price or tax liability	$167,378 $295.2 p/Share	567 Reduced 2.48%	22,312 Common Stock
Feb 17 2021	BUY Exercise of conversion of derivative security	-	5,030 Added 18.02%	22,879 Common Stock
Feb 17 2021	BUY Grant, award, or other acquisition	-	8,047 Added 20.95%	30,359 Common Stock
Jan 29 2021	SELL Open market or private sale	$279,698 $286.87 p/Share	975 Reduced 5.18%	17,849 Common Stock
Jan 29 2021	BUY Exercise of conversion of derivative security	$26,666 $27.35 p/Share	975 Added 4.92%	18,824 Common Stock

SGG

Scott G Ginn

EVP, CFO & COO

Baton Rouge, LA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMED shares.

Notify only if

Value

Insider Trading

Get notified when an Amedisys Inc insider buys or sells AMED shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMEDISYS INC

Track Activities on AMED

Account